SURPASS-1 SURPASS-2 :
Certain patients should refrain from semaglutide use, particularly those with a personal or familial history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or substance misuse issues
Hypersensitivity Reactions Inform patients that serious hypersensitivity reactions have been reported during postmarketing use of BYETTA
Most patients experience peak nausea during the first 24 weeks at each dose level, with symptoms gradually improving as your body adapts
Samsung Biologics secured $1.31.4 billion in new contracts in 20242025 and is building its fifth plant in Incheon (600,000+ liters, operational H2 2026), cementing the site as the worlds largest single-location biologics manufacturing hub
"There are limited long-term studies of these drugs on patients with obesity, particularly those who do not have diabetes or other related chronic conditions." Prior auth, AI, provider directories A host of new actions addressing prior auth is proposed in the rule